ReviewInfection & chemotherapy2021

The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.

Manoj Kumar Reddy Somagutta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.